What a GHRP-2 dose actually costs

Cost per dose is two numbers, not one

The price on a listing is a price per vial. It is not a price per dose, and the two only line up if the dose you use divides cleanly into the vial contents. So cost per dose has two inputs: what you paid, and how many whole doses the vial actually produces.

The second number is the one people get wrong. A vial does not give you "as much as you need". It gives you a fixed quantity of peptide in milligrams, and you can only draw whole doses out of it. Whatever is left at the bottom that is smaller than one dose is stranded. You paid for it and you cannot use it as a dose.

So the working is: vial price, divided by whole doses per vial. Not vial price divided by milligrams, unless your dose happens to be exactly one milligram. The table on this page supplies the divisor for a 0.2 mg dose. You supply the price.

What the table on this page shows

Two things are worth pulling out. First, at a 0.2 mg dose, both vial sizes divide with nothing left over. Stranded product is 0 mg and wasted product is 0% in both rows. That is worth noticing, because most dose-and-vial combinations across peptides leave a partial dose behind.

Second, the 10 mg vial produces exactly twice the doses of the 5 mg vial at the same dose size. That means the comparison between the two sizes collapses into a single question: does the larger vial cost less than twice the smaller one? If it does, cost per dose is lower. If it costs exactly double, the two are identical on a per-dose basis and the choice comes down to other factors, such as how long an opened vial sits before you finish it.

Because waste is zero in both rows, cost per dose here is just a restatement of price per milligram. There is no hidden penalty in either size at this dose. That is not true at every dose size, which is why the table is built around a specific one rather than presented as a general rule.

When a dose does not divide evenly

Listings for GHRP-2 also show 0.1 mg and 0.3 mg doses. This page computes only the 0.2 mg case, so treat the zero-waste result as specific to that dose, not as a property of the vials themselves.

The general shape of the problem: divide vial contents by dose size and take the whole number. Anything left over is a fraction of a dose. You can discard it, in which case it is pure cost, or carry it into a partial draw, which changes what you are administering. This site does not tell you which to do, because that is a decision about what enters your body and there is no medical review behind these pages.

What you can do is run the division before you buy. If a dose size leaves a remainder in one vial size and not another, the true cost gap between those vials is wider than the sticker prices suggest.

Water volume changes nothing about cost

GHRP-2 is sold as a dried powder and reconstituted with bacteriostatic water. Volumes of 1 mL, 2 mL and 3 mL all appear in common use. Adding more water does not add peptide. A 5 mg vial holds 5 mg whether you put 1 mL or 3 mL into it.

What the water volume changes is concentration, and therefore how many syringe units correspond to one dose. More water means a larger, easier-to-measure volume per dose. Less water means a smaller volume and more sensitivity to error in the draw. Neither affects doses per vial and neither affects cost per dose.

Reconstitution volume is often discussed as if it were an economic choice. It is not. It is a measurement-precision choice. The cost arithmetic is settled entirely by vial size and dose size.

What this page does not answer

There is no reliable human pharmacokinetic data for GHRP-2 that this site is willing to rely on. So there is nothing here about half life, how long it takes to clear, or whether it accumulates with repeated use. The arithmetic above concerns milligrams, milliliters and division. Nothing more.

That limit has a direct consequence for cost. If you do not know how often a dose would be repeated, you cannot convert cost per dose into cost per week or cost per month. Anyone quoting a monthly figure for GHRP-2 is supplying a dosing frequency from somewhere, and this page is not that somewhere.

GHRP-2 is not approved by any regulator for human use. This page carries no medical review. It does not tell you what dose to use, what to expect, whether it is safe, or whether it works. Those are questions for a clinician, not a calculator.

What we do not know

We hold no reliable human pharmacokinetic data for GHRP-2, so this site makes no claims about its half life, how long it takes to clear, or how it accumulates. The arithmetic below concerns concentration and volume only.

This page answers arithmetic and handling questions. It does not tell you what dose to take, what to expect, or whether anything is appropriate for you, and there is no medical review behind it.

Common questions

How many doses are in a 5 mg GHRP-2 vial?

At a 0.2 mg dose, a 5 mg vial yields 25 whole doses. Nothing is stranded, so the full 5 mg is usable at that dose size. At other dose sizes the count differs and a remainder may be left behind.

Is the 10 mg vial cheaper per dose than the 5 mg vial?

Only if it costs less than twice as much. The 10 mg vial gives 50 whole doses at 0.2 mg against 25 from the 5 mg vial, exactly double. Since neither size strands any product at that dose, cost per dose tracks price per milligram directly.

Does using more bacteriostatic water make a vial go further?

No. Water adds volume, not peptide. A 5 mg vial contains 5 mg whether you reconstitute with 1 mL, 2 mL or 3 mL. The volume you choose affects concentration and how many syringe units a dose occupies, not how many doses the vial contains.

What does stranded product mean?

It is peptide left in the vial that is smaller than one whole dose. You paid for it but cannot draw it as a full dose. At a 0.2 mg dose, both the 5 mg and 10 mg vials strand 0 mg, which is why waste shows as 0% in the table.

Can you tell me how much GHRP-2 to take?

No. This page performs arithmetic on vial sizes and dose sizes that appear in listings. It does not recommend a dose, predict effects, or assess safety. GHRP-2 is not approved by any regulator for human use and this site has no medical review process.